Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high‐risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities
Ravandi, Farhad, Issa, Jean‐Pierre, Garcia‐Manero, Guillermo, O'Brien, Susan, Pierce, Sherry, Shan, Jianqin, Borthakur, Gautam, Verstovsek, Srdan, Faderl, Stefan, Cortes, Jorge, Kantarjian, Hagop
Published in Cancer (15.12.2009)
Published in Cancer (15.12.2009)
Get full text
Journal Article
Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence
Faderl, Stefan, Ferrajoli, Alessandra, Wierda, William, O'Brien, Susan, Lerner, Susan, Keating, Michael J.
Published in Cancer (15.05.2010)
Published in Cancer (15.05.2010)
Get full text
Journal Article
Outcomes in Older Adults with Newly Diagnosed, High-Risk/Secondary Acute Myeloid Leukemia (AML) Who Achieved Remission with CPX-351 Versus 7+3 Induction: Exploratory Analysis of a Phase 3 Study
Faderl, Stefan, Cortes, Jorge E., Ritchie, Ellen K., Ryan, Robert J., Chiarella, Michael, Schiller, Gary J.
Published in Clinical lymphoma, myeloma and leukemia (01.09.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2019)
Get full text
Journal Article
Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapse
Ravandi, Farhad, Kantarjian, Hagop, Faderl, Stefan, Garcia-Manero, Guillermo, O’Brien, Susan, Koller, Charles, Pierce, Sherry, Brandt, Mark, Kennedy, Deborah, Cortes, Jorge, Beran, Miloslav
Published in Leukemia research (01.06.2010)
Published in Leukemia research (01.06.2010)
Get full text
Journal Article
Gemtuzumab ozogamicin with fludarabine, cytarabine, and granulocyte colony stimulating factor (FLAG‐GO) as front‐line regimen in patients with core binding factor acute myelogenous leukemia
Borthakur, Gautam, Cortes, Jorge E., Estey, Elihu E., Jabbour, Elias, Faderl, Stefan, O'Brien, Susan, Garcia‐Manero, Guillermo, Kadia, Tapan Mahendra, Wang, Xuemei, Patel, Keyur, Luthra, Rajyalakshmi, Koller, Charles, Brandt, Mark, Ravandi, Farhad, Kantarjian, Hagop
Published in American journal of hematology (01.10.2014)
Published in American journal of hematology (01.10.2014)
Get full text
Journal Article
Liposomal Cytarabine and Daunorubicin (CPX-351) in Combination with Gemtuzumab Ozogamicin (GO) in Relapsed Refractory (R/R) Patients with Acute Myeloid Leukemia (AML) and Post-Hypomethylating Agent (Post-HMA) Failure High-Risk Myelodysplastic Syndrome (HR-MDS)
Ramos Perez, Jorge M., Kadia, Tapan M., Montalban-Bravo, Guillermo, Faderl, Stefan, Sasaki, Koji, Daver, Naval, DiNardo, Courtney D., Masarova, Lucia, Ferrajoli, Alessandra, Jabbour, Elias, Borthakur, Gautham, Al Azzawi, Hind, Pemmaraju, Naveen, Konopleva, Marina, Pierce, Sherry A., Garcia-Manero, Guillermo, Andreeff, Michael, Kantarjian, Hagop M., Ravandi, Farhad, Alvarado, Yesid
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Higher Dose of CPX-351 Is Associated with Prolonged Hematologic Recovery: Results from an Interim Safety Analysis of the Randomized, Phase III AMLSG 30-18 Trial
Gaidzik, Verena I, Mayr-Benedikter, Verena, Weber, Daniela, Schrade, Anika, Krauter, Jürgen, Walz, Juliane S., Hebart, Holger, Schultheis, Beate S., Basara, Nadezda, Dietl, Elisabeth, Kapp-Schwoerer, Silke, Feuring-Buske, Michaela, Thol, Felicitas, Heuser, Michael, Faderl, Stefan, Wagner, Anthony J., Saadati, Maral, Krzykalla, Julia, Benner, Axel, Ganser, Arnold, Döhner, Konstanze, Paschka, Peter, Döhner, Hartmut
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Frontline HCVAD with Nelarabine and Peg-Asparaginase in T-Acute Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LBL): Updated Results of a Phase II Trial
Maiti, Abhishek, Jabbour, Elias, Jain, Nitin, Borthakur, Gautam, Kadia, Tapan M., Burger, Jan A., Wierda, William G., Konopleva, Marina, Alvarado, Yesid, Short, Nicholas J., Faderl, Stefan, O'Brien, Susan M., Ferrajoli, Alessandra, Kornblau, Steven M., Daver, Naval, Pemmaraju, Naveen, Bose, Prithviraj, Thompson, Philip A., Khoury, Joseph D., Balkin, Hayley, Kelly, Mary, Azzawi, Hind, Garris, Rebecca, Garcia-Manero, Guillermo, Kantarjian, Hagop M., Ravandi, Farhad
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Phase II trial of HyperCVAD and Dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia
Benjamini, Ohad, Dumlao, Theresa Liu, Kantarjian, Hagop, O'Brien, Susan, Garcia‐Manero, Guillermo, Faderl, Stefan, Jorgensen, Jeffrey, Luthra, Rajyalakshmi, Garris, Rebecca, Thomas, Deborah, Kebriaei, Partow, Champlin, Richard, Jabbour, Elias, Burger, Jan, Cortes, Jorge, Ravandi, Farhad
Published in American journal of hematology (01.03.2014)
Published in American journal of hematology (01.03.2014)
Get full text
Journal Article
A Single Institution Retrospective Review of Characteristics and Outcomes of Patients Requiring Chronic Dose Reduction of TKIs Given As Front-Line Therapy for Chronic Phase CML
Koprivnikar, Jamie L., McCloskey, James K., Wang, Yucai, Stanislaus, Genique, Goldberg, Stuart L., Faderl, Stefan
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
PEG-IFN-α-2b therapy in BCR-ABL-negative myeloproliferative disorders : Final result of a phase 2 study
JABBOUR, Elias, KANTARJIAN, Hagop, VERSTOVSEK, Srdan, CORTES, Jorge, THOMAS, Deborah, GARCIA-MANERO, Guillermo, FERRAJOLI, Alessandra, FADERL, Stefan, RICHIE, Mary Ann, BERAN, Miloslav, GILES, Francis
Published in Cancer (01.11.2007)
Published in Cancer (01.11.2007)
Get full text
Journal Article
TP53 Mutations Determine Outcome of Patients (pts) with High-Risk Myelodysplastic Syndrome (HRMDS) and Acute Myelogenous Leukemia (AML) Regardless of Karyotype and ELN Risk Stratification
McCloskey, James K., McKenna, Marshall, Koprivnikar, Jamie L., Depadova, Samantha, Stanislaus, Genique, Goldberg, Stuart L., Faderl, Stefan
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Features and Outcome of Patients (Pts) with New Diagnosis of Acute Myeloid Leukemia (AML) with Monocytic Differentiation (AML-Mo) Following Standard Induction Therapy. Do We Need a Different Strategy?
McCloskey, James K., Depadova, Samantha, Koprivnikar, Jamie L., Andrews, Tracy, McKenna, Marshall, Stanislaus, Genique, Goldberg, Stuart L., Faderl, Stefan
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
PEG-IFN-alpha-2b therapy in BCR-ABL-negative myeloproliferative disorders: final result of a phase 2 study
Jabbour, Elias, Kantarjian, Hagop, Cortes, Jorge, Thomas, Deborah, Garcia-Manero, Guillermo, Ferrajoli, Alessandra, Faderl, Stefan, Richie, Mary Ann, Beran, Miloslav, Giles, Francis, Verstovsek, Srdan
Published in Cancer (01.11.2007)
Published in Cancer (01.11.2007)
Get full text
Journal Article
Outcomes with Augmented Hyper-CVAD (AHCVAD), a Pediatric Inspired HCVAD-Based Regimen, for Adults Younger Than 50 Years of Age with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
McCloskey, James K, Stanislaus, Genique, Koprivnikar, Jamie L., Andrews, Tracy, Elizabeth, Jones, Marcotulli, Danielle, Perry, Grace, Goldberg, Stuart L., Faderl, Stefan
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics
Vitale, Candida, Falchi, Lorenzo, Ten Hacken, Elisa, Gao, Hui, Shaim, Hila, Van Roosbroeck, Katrien, Calin, George, O'Brien, Susan, Faderl, Stefan, Wang, Xuemei, Wierda, William G, Rezvani, Katayoun, Reuben, James M, Burger, Jan A, Keating, Michael J, Ferrajoli, Alessandra
Published in Clinical cancer research (15.05.2016)
Published in Clinical cancer research (15.05.2016)
Get full text
Journal Article
Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia
Ravandi, F, Arana Yi, C, Cortes, J E, Levis, M, Faderl, S, Garcia-Manero, G, Jabbour, E, Konopleva, M, O'Brien, S, Estrov, Z, Borthakur, G, Thomas, D, Pierce, S, Brandt, M, Pratz, K, Luthra, R, Andreeff, M, Kantarjian, H
Published in Leukemia (01.07.2014)
Published in Leukemia (01.07.2014)
Get full text
Journal Article
Five-year final results of a phase III study of CPX-351 versus 7+3 in older adults with newly diagnosed high-risk/secondary AML
Lancet, Jeffrey E., Uy, Geoffrey L., Newell, Laura F., Lin, Tara L., Ritchie, Ellen K., Stuart, Robert K., Strickland, Stephen Anthony, Hogge, Donna, Solomon, Scott R., Bixby, Dale, Kolitz, Jonathan E., Schiller, Gary J., Wieduwilt, Matthew Joseph, Ryan, Daniel H., Faderl, Stefan, Chang, Yu-Lin, Cortes, Jorge
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Prognostic significance of alterations in IDH enzyme isoforms in patients with AML treated with high‐dose cytarabine and idarubicin
Ravandi, Farhad, Patel, Keyur, Luthra, Rajyalakshmi, Faderl, Stefan, Konopleva, Marina, Kadia, Tapan, Brandt, Mark, Pierce, Sherry, Kornblau, Steven, Andreeff, Michael, Wang, Xuemei, Garcia‐Manero, Guillermo, Cortes, Jorge, Kantarjian, Hagop
Published in Cancer (15.05.2012)
Published in Cancer (15.05.2012)
Get full text
Journal Article